rEla1;sshIL-1β |
Pancreatic atrophy, dilation of ducts occurred secondary to proximal fibrotic stenosis, increase acinar proliferation and apoptosis, increased expression of chemokines and cytokines
Crossing in a p53 mutation to obtain Elastase sshIL-1β*p53R172H/+ results in the development of PanINs and lesions indicative of acinar to ductal metaplasia
Exposure to aqueous extract of cigarette smoke or Snus containing diet results in ductal epithelia flattening and proliferation, and glandular atrophy
High penetrance
|
76,254
|
rEla1;mPRSS1R122H (hereditary pancreatitis)
|
|
63 |
rEla1;hPRSS1R122H/N29I (hereditary pancreatitis)
|
|
64 |
PACE-try(on) Ela-creERT;ratPRSSII (hereditary pancreatitis)
|
AP only, rapid caspase-3 activation, apoptosis with delayed necrosis, loss of acinar cells leads to replacement with fatty tissue.
Chronic inflammation or fibrosis does not develop.
|
65
|
Ela1-cre;PERK−/−
|
Hyperglycemic by 4 wks
Induction of ER stress response, nonapoptotic acinar cells death pronounced inflammation
Exocrine and endocrine insufficiency
|
255 |
Ela1-LTab (Ela1-LTβ) |
Model of AIP, overexpression of lymphotoxin beta
Formation of B and T cell zones (tertiary lymphoid tissues)
Systemic autoimmune response
Chronic inflammation (in pancreas)
|
256 |
PDX1-cre;IKKα−/− |
Elevated serum amylase and lipase
progressive acinar cell vacuolization and death, interstitial fibrosis, inflammation, and compensatory proliferation
|
257 |
PDX1-cre;Kif3a−/−
|
By 2 wks. acinar to ductal metaplasia and periductal fibrosis is evident
By 12wks, acinar cells are replaced by adipose
By 6mo, pancreata composed of enlarging cysts
|
258 |
PDX1-cre;SRF−/− |
After weaning, mice develop profound morphological alterations of the exocrine pancreas, which were reminiscent of severe pancreatitis.
massive acinar injury, Nuclear Factor Kappa B activation and proinflammatory cytokine release leads to complete destruction of the exocrine pancreas and its replacement by adipose tissue
|
259 |
Pft1a-creex1; Atg5−/−
|
Greater penetrance in male
Inflammation, necrosis, acinar-to-ductal metaplasia, acinar hypertrophy and degeneration, increased ROS, decreased glutamate metabolism, reduced autophagy, increased p62, ER and mitochondrial stress
|
260 |
Mist1-creERT2;XBP1+/− |
|
114,261 |
hInsulin;TGFβ |
|
262 |
bK5; COX-2 |
|
263 |
hK8 |
Overexpression of human keratin 8
Exocrine pancreas alterations, includes dysplasia, loss of acinar architecture, redifferentiation of acinar to ductal cells, inflammation, fibrosis, and substitution of exocrine by adipose tissue, as well as increased cell proliferation and apoptosis.
Extra pancreatic epithelial changes also observed
|
264,265 |
CPA1N356K
|
C57Bl/6 mice harbor human p.N256K mutation in exon 7 of mouse Cpa1 locus
At 3 mo., pancreata begin to atrophy (decrease weight) with 35–40% decrease @ 6 mo
Loss of acini (30% by 12 mo), inflammatory infiltrate, presence of pseudotubular complexes (acinar-to ductal metaplasia), widespread fibrotic changes
At 1 mo., elevated circulating amylase that is lost by 3 mo
Elevated intrapancreatic trypsin and markers of endoplasmic reticulum stress
|
266 |
SPINK3−/− (hereditary pancreatitis) |
Pancreata initially develop normally
acinar degeneration starts around E16.5
Rapid onset cell death begins within days of birth
Mice die by P14.5
|
267–269 |
D23A (hereditary pancreatitis) |
T7D23A knock-in mouse carries a heterozygous p.D23A mutation in mouse cationic trypsinogen (isoform T7) on a C57BL/6N background
Pancreata are normal for first 2–3 weeks of life, with diminution in size visible by 2 months
4–5 weeks of age
40% exhibit typical AP at 4–5 weeks, characterized by edema, inflammatory infiltrate (dominated by neutrophils and macrophages), and localized necrosis
>50% exhibit minimal parenchyma and widespread regeneration including fibrosis and stellate cell activation
Elevated amylase in 40% of mice
2–12 months of age
Elevated intrapancreatic trypsin activity
Adipose replacement dominated, while inflammatory infiltrate decreased
Distorted ducts surrounded by prominent fibrosis
No calcifications and no loss of islets observed
|
66 |
LXRβ−/− |
Liver X receptor β was removed using cre-transgenic deleter mouse strain
Inflammation, duct dilation, fibrosis
Pancreatic exocrine insufficiency
|
270 |
LAMP2−/−
|
Begins with acinar cell vacuolization and progresses to severe damage, macrophage infiltration, and acinar cell death
Decreased amylase, increased MPO, Caspase-3
|
271 |
MHCII−/− (aged) |
At 6 mo, periductal lymphocytic infiltrate observed that progresses to selective acinar cell destruction
Significant decrease in amylase and lipase
Adoptive transfer of splenic mononuclear cells confers disease upon recipient
|
272 |
E2F1−/−/E2F2 −/−
|
endocrine and exocrine cell dysplasia
a reduction in the number and size of acini and islets, and their replacement by ductal structures and adipose tissue.
Mutant pancreatic cells exhibit increased rates of DNA replication but also of apoptosis, resulting in severe pancreatic atrophy
|
273 |
IKK2 CA
constitutively active, inducible |
CMVrtTA X tetO-IKK2-EE(IKK2) CA
Doxycycline induces constitutive IKK2 activity via S177E and S181E mutations
only minor damage, leukocyte infiltration, elevated RANTES and TNFα
Ela1-rtTA X luciferase-(tetO) 7-IKK2 CA, Ela-creERT X LSL-IKK2
Tamoxifen induces constitutive IKK2 activity in acinar cells
Results in edema, immune infiltration, necrosis, elevated lipase, and fibrosis
Severity increased by co-expressing p65
|
126,127,274 |
MRL-Mplpr/lpr (autoimmune pancreatitis, AIP) |
Express lymphoproliferative gene (lpr)
Incidence of pancreatitis is significantly greater in females, with the highest incidence (74%) in mice 34–38 weeks
spontaneous inflammatory lesions characterized by mononuclear cell infiltration, acini destruction, and replacement of parenchyma by adipose
Treating MRL-Mp mice with repeated injections of polyinosinic-polycytidylic acid drives a Type I AIP, characterized by enhanced levels of IgG4 antibodies which is associated with systemic IgG4-related disease.
|
275–277 |